ReleaseWire

Candy Crush Saga is one of the most addictive, and often one of the most infuriating games ever created. It’s simple game mechanic, colorful display and fun sounds make the game surprisingly engaging and often incredibly difficult. In order to progress, many players need to seek advice on how to beat certain levels. Candy Crush Tuts is a resource center to address this very need, and it has recently redesigned its website in order to make it easier than ever for their thriving community to unlock the secrets to victory.

Baker, Bloomber & Associates is a Texas based firm with great experience, efficiency and expertise in dealing with issues related to the occasional problems with the cash flow that construction industry has. The company offers the best in class, effective yet economic bad debt recovery solutions to industries, organizations, corporate and individuals.

The results of a pilot survey focusing on the care of the dying have been released.

Reportstack, provider of premium market research reports announces the addition of US Parkinson's Disease Drug Pipeline Analysis market report to its offering Parkinsons disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds USD 20 billion annually. The risk of this disease increases with age, thus implying that as the population in the US gets older, the impact of this disease on the financial and public health would also increase. Approximately 60,000 Americans are diagnosed with Parkinson's disease each year, and this number does not reflect the thousands of cases that go undetected.

Reportstack, provider of premium market research reports announces the addition of US Colorectal Cancer Drug Pipeline Analysis market report to its offering Among all the regions affected with colorectal cancer, the US would continue to account for a giants share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die of this type of cancer in the US every year. In 2013, close to 142,820 people new cases are estimated to be diagnosed with colorectal cancer, including 102,480 case of colon cancer and 40,340 cases of rectal cancer.

Reportstack, provider of premium market research reports announces the addition of US Cancer Vaccine Pipeline Analysis market report to its offering Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Consequently, many companies are expected to enter this emerging and highly profitable field of preventing, treating, and potentially curing cancer. Mercks Gardasil, a Prophylactic cancer vaccine, along with GSKs Cervarix are some of the first vaccines to have gained attention globally with their blockbuster status.

Reportstack, provider of premium market research reports announces the addition of Orphan Drugs for Cancer Pipeline Analysis market report to its offering A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed for treating rare cancer diseases like solid tumor of the pancreas and thyroid, blood cancer, melanoma, and others.

Reportstack, provider of premium market research reports announces the addition of Global Vaccine Market Pipeline Analysis market report to its offering The global vaccine market is characterized into human and animal vaccines. The segment of human vaccines is further sub-divided into four groups namely, pediatrics, adolescents, adults and elderly. Though the vaccines segment forms a very small portion of the global pharmaceutical drug sales(2-3%), the growth rate in this market has been extraordinary. This segment has grown at a high rate of 10-15% annually as compared to the overall pharmaceutical industry which grows at 5-7% per year.

Reportstack, provider of premium market research reports announces the addition of Global RNAi Drug Pipeline Analysis market report to its offering Global RNAi Drug Pipeline Analysis by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. Research report covers all the ongoing drugs being developed in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the RNAi technology associated with the various diseases.

Reportstack, provider of premium market research reports announces the addition of South Korea Biosimilar Market Analysis market report to its offering South Korea has emerged as one of the strategic location for the development of biosimilars on the global level. Among the various emerging countries identified for development of biosimilars, South Korea is one of the most promising countries where pharmaceutical companies have identified huge investment potentials for the drug development process. One of the major reasons for the attractiveness of South Korea is the end of patent protection for some blockbuster drugs in the coming years and the need for novel therapeutics. Offering the advantages of favorable government and business conducive environment, the South Korean biosimilars market is poised for significant and rapid growth in the future years. There are many favorable steps undertaken by the government in this regard, some of them being tax holidays, tax concessions, cash grant, site location support and financial support for pharmaceutical companies investing in Korea.

Reportstack, provider of premium market research reports announces the addition of China Shale Gas Sector Analysis market report to its offering China is basking in the glory of its recent worlds largest shale finds. With almost 25% more reserves than the United States, China is dreaming about an even bigger energy revolution than the one seen in America. If estimates are to be believed then this 1,275 Trillion Cubic Feet of shale gas reserves found in China will last for about 300 years at the present rate of production and consumption. Since Chinese shale gas scenario is in its early years, the future is large and as of now looks promising. The practical production currently is zero, with a couple of experimental wells producing only 10,000 meters of gas per day but nothing substantial.

Reportstack, provider of premium market research reports announces the addition of China Aviation Industry Opportunity Analysis market report to its offering Aviation industry in China began way back in 1951 with some domestic travel and agricultural services being their primary goals. Greater growth happened much later in the mid seventies. The industry posted major growth in its revival phase between 1977 and 1996. After 1996, there was a general period of growth in the economy and this reflected in the volume of general aviation operations and services that have increased throughout China each year. It has shown double digit growth in aircraft numbers and in the number of flight hours since 2001 while consumer aviation has been growing at a rate of 21% since 1996.

Reportstack, provider of premium market research reports announces the addition of India Reverse Logistics Market Analysis market report to its offering Reverse logistics has been an important issue among industries in the past few years. While it was viewed in the past as a secondary operation to the new product side of business, it has now moved to the forefront as a strategic and integral part of the quest to increase customer satisfaction. This has meant that the responsibility of producers now goes beyond the production and distribution to the responsibility of the end of product life cycle. Being aware of the importance and benefits of focusing on reverse logistics, companies are now looking at it with renewed interest. They are now trying to incorporate it as part of their supply chain, either as fully home grown processes, or partially or fully outsourced ones. Against this background it is important to understand how the process works and the different ways or models that are being followed besides the activities that are involved. India is seen as one of the most promising and dynamic reverse logistics markets in the world. The increasing customer demands for better aftermarket services, awareness of their consumer rights and the growth of the e-business channel are few factors which are leading adoption of reverse logistics practices in supply chain process. While reverse logistics practices in recent times have been have been seen as environmentally friendly and adding more weight to corporate social responsibilities, increased competition and customer demand has made manufacturers and retailers to look at aspects like warranty, service and returns with more concern. In India, reverse logistics is seen as a sunrise sector within logistics. Since it is an industry that is still evolving, there is excitement and interest over the sizable business opportunity but wariness regarding the high execution risk. There is also the awareness and acknowledgement of the fact that within Indian conditions reverse logistics can be a very tedious and specialized job given the vast geography and presence of various sub market landscape.

Reportstack, provider of premium market research reports announces the addition of Global Orphan Drug Market Outlook 2018 market report to its offering The global pharmaceutical industry has been experiencing a slow growth in recent years owing to many factors such as expiration of patents, competition from generic drugs segment, exhausting pipelines, and an increasingly stringent regulatory framework. It is most likely that many blockbuster drugs would lose their exclusivity in the next 5 year horizon.

Reportstack, provider of premium market research reports announces the addition of US Cancer Vaccine Market Outlook 2018 market report to its offering Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. Therapeutic or Treatment vaccines are targeted at treating an existing cancer by strengthening the bodys natural defences against the cancer and the Prophylactic or Preventive vaccines are used to prevent cancer from developing in healthy people. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Consequently, many companies are expected to enter this emerging and highly profitable field of preventing, treating, and potentially curing cancer.

Reportstack, provider of premium market research reports announces the addition of Europe Orphan Drug Market Outlook 2018 market report to its offering The concept of rare diseases and the idea that a special attention needs to be given to this sector has been taking shape in Europe since the 1990s. ever since then the political aspects and initiatives related to orphan medicinal products have been emerging at both the EU level and at the level of member states individually.

Reportstack, provider of premium market research reports announces the addition of US Orphan Drug Market Outlook 2018 market report to its offering n the largest market for orphan drugs, USA, there was a shortage of adequate therapies for treating many rare diseases. These therapies were not developed as companies did not expect these drugs to be highly profitable. Hence there was a lack of interest and thus investment on the part of pharma companies in the USA. Therefore, the FDA introduced incentives for developing such drugs. This step taken by the FDA was successful in creating a thriving market for orphan drugs.

Reportstack, provider of premium market research reports announces the addition of India Refurbished Medical Imaging Equipment Market Analysis market report to its offering Refurbishment is a well-established element of the global healthcare economy and has been there since long and is here to stay till the time there is a need for medical equipments. It is one of the pressing needs in todays healthcare scenario where quality and cost effectiveness go hand in hand, where budgetary constraints dominate the purchase practices of healthcare providers.

Reportstack, provider of premium market research reports announces the addition of India Cord Blood Stem Cell Banking Market market report to its offering Cord Blood Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued around US$ 60 Million in 2013 and further expected to surpass US$ 400 Million by 2018. The current cord blood stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for cord blood stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of cord blood stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of cord blood stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies. Many factors have actively contributing towards this overwhelming success cord blood stem cell banking in India and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters. India is poised to emerge as the largest source for umbilical cord blood given the very high birth rate in the world. Since umbilical cords are the richest source of stem cells, it's no surprise then that leading stem cell banking companies are keen on shifting their stem cell bases in India. Till date around six major private players, both Indian as well subsidiaries of international companies are operating in the stem cell banking market of India. India Cord Blood Stem Cell Banking Market research report outlines following aspects related to booming stem cell banking in India: India Stem Cell Research & Therapy Market Overview Cord Blood Stem Cell Banking Market Overview Market Dynamics & Cost Analysis Future Growth Avenues Preferred Business Model for Cord Blood Stem Cell Banks Regulatory & Policy Framework Institutional Support Framework Competitive Landscape

Reportstack, provider of premium market research reports announces the addition of Global RNA Interference (RNAi) Therapy Market Outlook 2018 market report to its offering The popularity of RNAi technology has been increasing in recent times as is has become a major component of basic research, and in drug discovery. Over the years this technology has become an integral part of the process of determining the functions of gene, in analyzing pathways, and in the validation of the target both in academia and in industry. Since discovery, RNA interference is considered to be a turning point for molecular biology, it is most likely that this technology would grow in terms of its popularity and the significant research activity would be recorded in order to develop efficient and safe drug delivery mechanisms based on the RNAi therapy. Being a powerful tool for the study of functional genomics, this therapy provides enables the scientist to successfully silence any gene with artificial triggers of RNAi and utilizing the cellular machinery for efficient targeting of complementary transcripts. There are specific strategic reasons for the pharmaceutical industry to take interest in developing RNAi-based therapeutics. With the existing product pipelines exhausting for the big pharma companies, they are currently looking into RNAi therapeutics as potential fields which would enable the pipelines to be filled. Additionally, these companies have identified RNAi therapeutics to have the capability to target those diseases which are considered to be undruggable by small-molecule compounds or biologics. Thus, by investing in RNAi therapeutics at an early stage, the pharma companies would be able to build a strong foothold and have a commanding position in the market once these RNAi-based drugs reached the market.

Reportstack, provider of premium market research reports announces the addition of Cancer Gene Therapy Market Analysis market report to its offering The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant share of more than 60% in the overall number of clinical studies. The reasons for cancer to become a preferred area of application for gene therapy are the significant unmet medical needs in cancer therapy, coupled with the large size of its market. Additionally, the ethical acceptance of gene therapy as a therapeutic solution also contributed to the shift of focus from monogenetic diseases to cancer.

Reportstack, provider of premium market research reports announces the addition of China Smart Grid Market Outlook 2018 market report to its offering China has emerged as the largest smart grid market in the world in recent years, given that the country is in the transition process of rebuilding its grid network to meet its power sector requirement and plans. The market presents strong growth opportunities given the fact that the State Grid Corp., the utility responsible for majority of the country grid network, plans to invest more than US$ 200 Billion in upgradation of existing conventional grid infrastructure to smart grid infrastructure in future. The Chinese government has looked ahead in terms of the needs of the countrys grid development, especially the smart grid projects. Their support has been in the form of favorable rules that understood the situation and paved the way for the necessary changes and institutions.

Reportstack, provider of premium market research reports announces the addition of COPD Drug Market Opportunity & Clinical Pipeline Analysis market report to its offering Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the variable airflow and airway hyper-responsiveness to many intrinsic, genetic and environmental stimuli. These disorders have become one of the major reasons for disability and death. The prevalence and incidence of this disease is increasing worldwide. Bronchodilators and polypharmacy dominates the treatment for this disease. It is expected that by 2020, COPD would account for more than 6 Million deaths across the globe annually. Inspite of significant investments in the development of novel agents to treat the disease, the COPD therapy area is generally dominated by inhaled bronchodilator therapies which only relieve symptoms, but do not completely cure the disease. There exist many opportunities for a disease-modifying therapy. However, the development of new COPD therapies is increasingly focusing on therapies which combine two bronchodilators into one inhaler.

Reportstack, provider of premium market research reports announces the addition of Pulmonary Drug Delivery Market & Clinical Pipeline Insight market report to its offering The demand for new and innovative drug delivery systems has been on a rising trend with the pharmaceutical companies concentrating on developing innovative methods for this area. It is the result of these continued efforts, which have led to the ever rising popularity of pulmonary drug delivery methods across the globe. Pulmonary drug delivery system uses the respiratory tract to deliver drugs into the lungs in order to treat diseases such as asthma, COPD and cystic fibrosis. This market has been attracting significant investments by the pharma companies with relation to development of novel treatment methods.

Reportstack, provider of premium market research reports announces the addition of Antibody Drug Conjugate Market Opportunity Analysis market report to its offering Ever since the first attempt in the 1980s to use antibody based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the tumor cell or tissue.